Paolo Cavazza, 10% Owner at SCICLONE PHARMACEUTICALS INC (SCLN), sold 6,728,469 shares at $5.25 ($35.3M) on 2012-04-30, disclosed to the SEC on 2012-05-02.
Open-market sale of $35.3M SCLN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.25 | 147,531 | $775K | 2.2% |
| 2 | $5.25 | 252,469 | $1.3M | 3.8% |
| 3 | $5.25 | 6,328,469 | $33.2M | 94.1% |
| Total | $5.25 avg | 6,728,469 | $35.3M | 100% |
| Filing → |
| SNGX | SELL | 2017-12-01 | $1.2M | — | Filing → |
| RGRX.OB | BUY | 2011-01-07 | $600K | — | Filing → |
| SNGX | BUY | 2010-06-21 | $2.4M | — | Filing → |